MedPath

HONEYBRAINS BIOTECH LLC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of HB-1 for Panic Disorder

Phase 2
Recruiting
Conditions
Panic Disorder
Mental Illness
Interventions
First Posted Date
2024-07-03
Last Posted Date
2025-03-05
Lead Sponsor
Honeybrains Biotech LLC
Target Recruit Count
240
Registration Number
NCT06483789
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

East Sydney Doctors, Darlinghurst, New South Wales, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Innovate Clinical Research, Waitara, New South Wales, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

NeuroCentrix, Carlton, Victoria, Australia

and more 10 locations

Safety and Efficacy of HB-1 for Panic Disorder

Phase 2
Completed
Conditions
Panic Disorder
Interventions
Drug: Placebo
First Posted Date
2021-10-08
Last Posted Date
2025-03-18
Lead Sponsor
Honeybrains Biotech LLC
Target Recruit Count
86
Registration Number
NCT05071430
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Richmond Behavioral Associates, Staten Island, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Collaborative Neuroscience Research, Garden Grove, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Uptown Research Institute, Chicago, Illinois, United States

and more 5 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath